EX-2.1
from 8-K
119 pages
Agreement and Plan of Merger Among: Amicus Therapeutics, Inc., a Delaware Corporation; Biomarin Pharmaceutical Inc., a Delaware Corporation; Lynx Merger Sub 1, Inc., a Delaware Corporation, Dated as of December 19, 2025
12/34/56
EX-2.1
from 8-K
82 pages
Agreement and Plan of Merger by and Among Amicus Therapeutics, Inc., Columbus Merger Sub Corp., Celenex, Inc. and Shareholder Representative Services LLC, as Shareholders’ Representative Dated as of September 19, 2018
12/34/56
EX-2.1
from 8-K
78 pages
Agreement and Plan of Merger by and Among Miamed, Inc., Amicus Therapeutics, Inc., Minervas Merger Sub, Inc. and MM Stockholders Representative LLC, Solely in Its Capacity as the Stockholders Representative July 5, 2016
12/34/56
EX-2.1
from 8-K/A
87 pages
Agreement and Plan of Merger by and Among Amicus Therapeutics, Inc., Cb Acquisition Corp., Callidus Biopharma, Inc. and Cuong Do, as Holder Representative Dated as of November 19, 2013
12/34/56
